Tamflo 0.8mg Capsule may cause excessive drowsiness with alcohol.
Tamflo 0.8mg Capsule is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Tamflo 0.8mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Tamflo 0.8mg Capsule is not indicated for use in women.
Tamflo 0.8mg Capsule does not usually affect your ability to drive.
Tamflo 0.8mg Capsule is safe to use in patients with kidney disease. No dose adjustment of Tamflo 0.8mg Capsule is recommended. However, limited information is available on the use of Tamflo 0.8mg Capsule in patients with end stage kidney disease. Please consult your doctor.
Tamflo 0.8mg Capsule should be used with caution in patients with severe liver disease. Dose adjustment of Tamflo 0.8mg Capsule may be needed. Please consult your doctor.
If you miss a dose of Tamflo 0.8mg Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More